{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:46:32Z","timestamp":1794491192480,"version":"4.9.1"},"publisher-location":"Cham","reference-count":138,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319096643","type":"print"},{"value":"9783319096650","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/978-3-319-09665-0_15","type":"book-chapter","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T02:05:10Z","timestamp":1418954710000},"page":"483-508","source":"Crossref","is-referenced-by-count":164,"title":["HDL in Infectious Diseases and Sepsis"],"prefix":"10.1007","author":[{"given":"Angela","family":"Pirillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberico Luigi","family":"Catapano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Danilo","family":"Norata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,1]]},"reference":[{"key":"15_CR1","doi-asserted-by":"publisher","first-page":"12766","DOI":"10.1073\/pnas.96.22.12766","volume":"96","author":"V Agnello","year":"1999","unstructured":"Agnello V, Abel G, Elfahal M, Knight GB, Zhang QX (1999) Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci U S A 96:12766\u201312771","journal-title":"Proc Natl Acad Sci U S A"},{"key":"15_CR2","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1161\/CIRCULATIONAHA.107.707349","volume":"117","author":"KO Badellino","year":"2008","unstructured":"Badellino KO, Wolfe ML, Reilly MP, Rader DJ (2008) Endothelial lipase is increased in vivo by inflammation in humans. Circulation 117:678\u2013685. doi: 10.1161\/CIRCULATIONAHA.107.707349","journal-title":"Circulation"},{"key":"15_CR3","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1097\/QAD.0b013e32834be088","volume":"25","author":"JV Baker","year":"2011","unstructured":"Baker JV, Neuhaus J, Duprez D, Cooper DA, Hoy J, Kuller L, Lampe FC, Liappis A, Friis-Moller N, Otvos J, Paton NI, Tracy R, Neaton JD, Group ISS (2011) Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy. AIDS 25:2133\u20132142. doi: 10.1097\/QAD.0b013e32834be088","journal-title":"AIDS"},{"key":"15_CR4","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0022-2275(20)39863-1","volume":"36","author":"CL Banka","year":"1995","unstructured":"Banka CL, Yuan T, de Beer MC, Kindy M, Curtiss LK, de Beer FC (1995) Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux. J Lipid Res 36:1058\u20131065","journal-title":"J Lipid Res"},{"key":"15_CR5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/joim.12081","volume":"274","author":"A Baragetti","year":"2013","unstructured":"Baragetti A, Norata GD, Sarcina C, Rastelli F, Grigore L, Garlaschelli K, Uboldi P, Baragetti I, Pozzi C, Catapano AL (2013) High density lipoprotein cholesterol levels are an independent predictor of the progression of chronic kidney disease. J Intern Med 274:252\u2013262. doi: 10.1111\/joim.12081","journal-title":"J Intern Med"},{"key":"15_CR6","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/nm1395","volume":"12","author":"TN Baral","year":"2006","unstructured":"Baral TN, Magez S, Stijlemans B, Conrath K, Vanhollebeke B, Pays E, Muyldermans S, De Baetselier P (2006) Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor. Nat Med 12:580\u2013584. doi: 10.1038\/nm1395","journal-title":"Nat Med"},{"key":"15_CR7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0022-2275(20)31690-4","volume":"42","author":"S Barlage","year":"2001","unstructured":"Barlage S, Frohlich D, Bottcher A, Jauhiainen M, Muller HP, Noetzel F, Rothe G, Schutt C, Linke RP, Lackner KJ, Ehnholm C, Schmitz G (2001) ApoE-containing high density lipoproteins and phospholipid transfer protein activity increase in patients with a systemic inflammatory response. J Lipid Res 42:281\u2013290","journal-title":"J Lipid Res"},{"key":"15_CR8","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","volume":"357","author":"PJ Barter","year":"2007","unstructured":"Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, Komajda M, Lopez-Sendon J, Mosca L, Tardif JC, Waters DD, Shear CL, Revkin JH, Buhr KA, Fisher MR, Tall AR, Brewer B (2007) Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 357:2109\u20132122. doi: 10.1056\/NEJMoa0706628","journal-title":"N Engl J Med"},{"key":"15_CR9","doi-asserted-by":"publisher","first-page":"41624","DOI":"10.1074\/jbc.M305289200","volume":"278","author":"B Bartosch","year":"2003","unstructured":"Bartosch B, Vitelli A, Granier C, Goujon C, Dubuisson J, Pascale S, Scarselli E, Cortese R, Nicosia A, Cosset FL (2003) Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J Biol Chem 278:41624\u201341630. doi: 10.1074\/jbc.M305289200","journal-title":"J Biol Chem"},{"key":"15_CR10","doi-asserted-by":"publisher","first-page":"8217","DOI":"10.1128\/JVI.79.13.8217-8229.2005","volume":"79","author":"B Bartosch","year":"2005","unstructured":"Bartosch B, Verney G, Dreux M, Donot P, Morice Y, Penin F, Pawlotsky JM, Lavillette D, Cosset FL (2005) An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies. J Virol 79:8217\u20138229. doi: 10.1128\/JVI.79.13.8217-8229.2005","journal-title":"J Virol"},{"key":"15_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1189\/jlb.0805445","volume":"80","author":"P Baruah","year":"2006","unstructured":"Baruah P, Dumitriu IE, Peri G, Russo V, Mantovani A, Manfredi AA, Rovere-Querini P (2006) The tissue pentraxin PTX3 limits C1q-mediated complement activation and phagocytosis of apoptotic cells by dendritic cells. J Leukoc Biol 80:87\u201395. doi: 10.1189\/jlb.0805445","journal-title":"J Leukoc Biol"},{"key":"15_CR12","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1096\/fj.05-5639fje","volume":"20","author":"JF Berbee","year":"2006","unstructured":"Berbee JF, van der Hoogt CC, Kleemann R, Schippers EF, Kitchens RL, van Dissel JT, Bakker-Woudenberg IA, Havekes LM, Rensen PC (2006) Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in gram-negative sepsis. Faseb J 20:2162\u20132164","journal-title":"Faseb J"},{"key":"15_CR13","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1128\/IAI.59.12.4614-4620.1991","volume":"59","author":"S Bhakdi","year":"1991","unstructured":"Bhakdi S, Klonisch T, Nuber P, Fischer W (1991) Stimulation of monokine production by lipoteichoic acids. Infect Immun 59:4614\u20134620","journal-title":"Infect Immun"},{"key":"15_CR14","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1161\/ATVBAHA.106.136325","volume":"27","author":"RS Birjmohun","year":"2007","unstructured":"Birjmohun RS, van Leuven SI, Levels JH, van\u2019t Veer C, Kuivenhoven JA, Meijers JC, Levi M, Kastelein JJ, van der Poll T, Stroes ES (2007) High-density lipoprotein attenuates inflammation and coagulation response on endotoxin challenge in humans. Arterioscler Thromb Vasc Biol 27:1153\u20131158. doi: 10.1161\/ATVBAHA.106.136325","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"15_CR15","doi-asserted-by":"publisher","first-page":"725102","DOI":"10.1155\/2013\/725102","volume":"2013","author":"F Bonacina","year":"2013","unstructured":"Bonacina F, Baragetti A, Catapano AL, Norata GD (2013) Long pentraxin 3: experimental and clinical relevance in cardiovascular diseases. Mediators Inflamm 2013:725102. doi: 10.1155\/2013\/725102","journal-title":"Mediators Inflamm"},{"key":"15_CR16","doi-asserted-by":"publisher","first-page":"32817","DOI":"10.1074\/jbc.272.52.32817","volume":"272","author":"B Bottazzi","year":"1997","unstructured":"Bottazzi B, Vouret-Craviari V, Bastone A, De Gioia L, Matteucci C, Peri G, Spreafico F, Pausa M, D'Ettorre C, Gianazza E, Tagliabue A, Salmona M, Tedesco F, Introna M, Mantovani A (1997) Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. J Biol Chem 272:32817\u201332823","journal-title":"J Biol Chem"},{"key":"15_CR17","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1182\/blood-2006-03-009266","volume":"108","author":"S Bozza","year":"2006","unstructured":"Bozza S, Bistoni F, Gaziano R, Pitzurra L, Zelante T, Bonifazi P, Perruccio K, Bellocchio S, Neri M, Iorio AM, Salvatori G, De Santis R, Calvitti M, Doni A, Garlanda C, Mantovani A, Romani L (2006) Pentraxin 3 protects from MCMV infection and reactivation through TLR sensing pathways leading to IRF3 activation. Blood 108:3387\u20133396. doi: 10.1182\/blood-2006-03-009266","journal-title":"Blood"},{"key":"15_CR18","doi-asserted-by":"crossref","first-page":"22190","DOI":"10.1016\/S0021-9258(18)41653-5","volume":"267","author":"F Breviario","year":"1992","unstructured":"Breviario F, d'Aniello EM, Golay J, Peri G, Bottazzi B, Bairoch A, Saccone S, Marzella R, Predazzi V, Rocchi M et al (1992) Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component. J Biol Chem 267:22190\u201322197","journal-title":"J Biol Chem"},{"key":"15_CR19","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1074\/jbc.273.7.4012","volume":"273","author":"Y Cao","year":"1998","unstructured":"Cao Y, Stafforini DM, Zimmerman GA, McIntyre TM, Prescott SM (1998) Expression of plasma platelet-activating factor acetylhydrolase is transcriptionally regulated by mediators of inflammation. J Biol Chem 273:4012\u20134020","journal-title":"J Biol Chem"},{"key":"15_CR20","doi-asserted-by":"publisher","first-page":"8063","DOI":"10.1128\/JVI.00193-07","volume":"81","author":"MT Catanese","year":"2007","unstructured":"Catanese MT, Graziani R, von Hahn T, Moreau M, Huby T, Paonessa G, Santini C, Luzzago A, Rice CM, Cortese R, Vitelli A, Nicosia A (2007) High-avidity monoclonal antibodies against the human scavenger class B type I receptor efficiently block hepatitis C virus infection in the presence of high-density lipoprotein. J Virol 81:8063\u20138071. doi: 10.1128\/JVI.00193-07","journal-title":"J Virol"},{"key":"15_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1128\/JVI.02199-08","volume":"84","author":"MT Catanese","year":"2010","unstructured":"Catanese MT, Ansuini H, Graziani R, Huby T, Moreau M, Ball JK, Paonessa G, Rice CM, Cortese R, Vitelli A, Nicosia A (2010) Role of scavenger receptor class B type I in hepatitis C virus entry: kinetics and molecular determinants. J Virol 84:34\u201343. doi: 10.1128\/JVI.02199-08","journal-title":"J Virol"},{"key":"15_CR22","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1097\/01.CCM.0000171183.79525.6B","volume":"33","author":"JY Chien","year":"2005","unstructured":"Chien JY, Jerng JS, Yu CJ, Yang PC (2005) Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit Care Med 33:1688\u20131693","journal-title":"Crit Care Med"},{"key":"15_CR23","doi-asserted-by":"publisher","first-page":"9613","DOI":"10.1073\/pnas.1103187108","volume":"108","author":"C Christoffersen","year":"2011","unstructured":"Christoffersen C, Obinata H, Kumaraswamy SB, Galvani S, Ahnstrom J, Sevvana M, Egerer-Sieber C, Muller YA, Hla T, Nielsen LB, Dahlback B (2011) Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M. Proc Natl Acad Sci USA 108:9613\u20139618. doi: 10.1073\/pnas.1103187108","journal-title":"Proc Natl Acad Sci USA"},{"key":"15_CR24","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1194\/jlr.M002295","volume":"51","author":"RW Clark","year":"2010","unstructured":"Clark RW, Cunningham D, Cong Y, Subashi TA, Tkalcevic GT, Lloyd DB, Boyd JG, Chrunyk BA, Karam GA, Qiu X, Wang IK, Francone OL (2010) Assessment of cholesteryl ester transfer protein inhibitors for interaction with proteins involved in the immune response to infection. J Lipid Res 51:967\u2013974. doi: 10.1194\/jlr.M002295","journal-title":"J Lipid Res"},{"key":"15_CR25","doi-asserted-by":"crossref","first-page":"9644","DOI":"10.1016\/S0021-9258(18)67562-3","volume":"261","author":"GA Coetzee","year":"1986","unstructured":"Coetzee GA, Strachan AF, van der Westhuyzen DR, Hoppe HC, Jeenah MS, de Beer FC (1986) Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition. J Biol Chem 261:9644\u20139651","journal-title":"J Biol Chem"},{"key":"15_CR26","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1172\/JCI34189","volume":"118","author":"D Cruz","year":"2008","unstructured":"Cruz D, Watson AD, Miller CS, Montoya D, Ochoa MT, Sieling PA, Gutierrez MA, Navab M, Reddy ST, Witztum JL, Fogelman AM, Rea TH, Eisenberg D, Berliner J, Modlin RL (2008) Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy. J Clin Invest 118:2917\u20132928. doi: 10.1172\/JCI34189","journal-title":"J Clin Invest"},{"key":"15_CR27","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1194\/jlr.M008086","volume":"51","author":"L Dai","year":"2010","unstructured":"Dai L, Datta G, Zhang Z, Gupta H, Patel R, Honavar J, Modi S, Wyss JM, Palgunachari M, Anantharamaiah GM, White CR (2010) The apolipoprotein A-I mimetic peptide 4F prevents defects in vascular function in endotoxemic rats. J Lipid Res 51:2695\u20132705. doi: 10.1194\/jlr.M008086","journal-title":"J Lipid Res"},{"key":"15_CR28","doi-asserted-by":"publisher","first-page":"31242","DOI":"10.1074\/jbc.M112.365924","volume":"287","author":"VL Dao Thi","year":"2012","unstructured":"Dao Thi VL, Granier C, Zeisel MB, Guerin M, Mancip J, Granio O, Penin F, Lavillette D, Bartenschlager R, Baumert TF, Cosset FL, Dreux M (2012) Characterization of hepatitis C virus particle subpopulations reveals multiple usage of the scavenger receptor BI for entry steps. J Biol Chem 287:31242\u201331257. doi: 10.1074\/jbc.M112.365924","journal-title":"J Biol Chem"},{"key":"15_CR29","doi-asserted-by":"publisher","first-page":"pii: 1000172","DOI":"10.4172\/2155-9880.1000172","volume":"2","author":"G Datta","year":"2011","unstructured":"Datta G, Gupta H, Zhang Z, Mayakonda P, Anantharamaiah GM, White CR (2011) HDL mimetic peptide administration improves left ventricular filling and cardiac output in lipopolysaccharide-treated rats. J Clin Exp Cardiolog 2:pii: 1000172. doi: 10.4172\/2155-9880.1000172","journal-title":"J Clin Exp Cardiolog"},{"key":"15_CR30","doi-asserted-by":"publisher","first-page":"10359","DOI":"10.1073\/pnas.92.22.10359","volume":"92","author":"SJ Kimpe De","year":"1995","unstructured":"De Kimpe SJ, Kengatharan M, Thiemermann C, Vane JR (1995) The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc Natl Acad Sci USA 92:10359\u201310363","journal-title":"Proc Natl Acad Sci USA"},{"key":"15_CR31","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.atherosclerosis.2012.02.032","volume":"222","author":"MM Llera de la","year":"2012","unstructured":"de la Llera MM, McGillicuddy FC, Hinkle CC, Byrne M, Joshi MR, Nguyen V, Tabita-Martinez J, Wolfe ML, Badellino K, Pruscino L, Mehta NN, Asztalos BF, Reilly MP (2012) Inflammation modulates human HDL composition and function in vivo. Atherosclerosis 222:390\u2013394. doi: 10.1016\/j.atherosclerosis.2012.02.032\/S0021-9150(12)00146-3","journal-title":"Atherosclerosis"},{"key":"15_CR32","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/00002030-200102160-00005","volume":"15","author":"M Depairon","year":"2001","unstructured":"Depairon M, Chessex S, Sudre P, Rodondi N, Doser N, Chave JP, Riesen W, Nicod P, Darioli R, Telenti A, Mooser V, Swiss HIVCS (2001) Premature atherosclerosis in HIV-infected individuals \u2013 focus on protease inhibitor therapy. AIDS 15:329\u2013334","journal-title":"AIDS"},{"key":"15_CR33","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1189\/jlb.0803371","volume":"75","author":"SN Diniz","year":"2004","unstructured":"Diniz SN, Nomizo R, Cisalpino PS, Teixeira MM, Brown GD, Mantovani A, Gordon S, Reis LF, Dias AA (2004) PTX3 function as an opsonin for the dectin-1-dependent internalization of zymosan by macrophages. J Leukoc Biol 75:649\u2013656. doi: 10.1189\/jlb.0803371","journal-title":"J Leukoc Biol"},{"key":"15_CR34","doi-asserted-by":"publisher","first-page":"29983","DOI":"10.1074\/jbc.M805631200","volume":"283","author":"A Doni","year":"2008","unstructured":"Doni A, Mantovani G, Porta C, Tuckermann J, Reichardt HM, Kleiman A, Sironi M, Rubino L, Pasqualini F, Nebuloni M, Signorini S, Peri G, Sica A, Beck-Peccoz P, Bottazzi B, Mantovani A (2008) Cell-specific regulation of PTX3 by glucocorticoid hormones in hematopoietic and nonhematopoietic cells. J Biol Chem 283:29983\u201329992. doi: 10.1074\/jbc.M805631200","journal-title":"J Biol Chem"},{"key":"15_CR35","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.imbio.2012.07.004","volume":"217","author":"A Doni","year":"2012","unstructured":"Doni A, Garlanda C, Bottazzi B, Meri S, Garred P, Mantovani A (2012) Interactions of the humoral pattern recognition molecule PTX3 with the complement system. Immunobiology 217:1122\u20131128. doi: 10.1016\/j.imbio.2012.07.004\/S0171-2985(12)00168-4","journal-title":"Immunobiology"},{"key":"15_CR36","doi-asserted-by":"publisher","first-page":"e1000310","DOI":"10.1371\/journal.ppat.1000310","volume":"5","author":"M Dreux","year":"2009","unstructured":"Dreux M, Dao Thi VL, Fresquet J, Guerin M, Julia Z, Verney G, Durantel D, Zoulim F, Lavillette D, Cosset FL, Bartosch B (2009) Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains. PLoS Pathog 5:e1000310. doi: 10.1371\/journal.ppat.1000310","journal-title":"PLoS Pathog"},{"key":"15_CR37","doi-asserted-by":"publisher","first-page":"25576","DOI":"10.1074\/jbc.272.41.25576","volume":"272","author":"PN Duchateau","year":"1997","unstructured":"Duchateau PN, Pullinger CR, Orellana RE, Kunitake ST, Naya-Vigne J, O'Connor PM, Malloy MJ, Kane JP (1997) Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of apolipoprotein L. J Biol Chem 272:25576\u201325582","journal-title":"J Biol Chem"},{"key":"15_CR38","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/IAI.60.2.596-601.1992","volume":"60","author":"K Emancipator","year":"1992","unstructured":"Emancipator K, Csako G, Elin RJ (1992) In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins. Infect Immun 60:596\u2013601","journal-title":"Infect Immun"},{"key":"15_CR39","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nature05654","volume":"446","author":"MJ Evans","year":"2007","unstructured":"Evans MJ, von Hahn T, Tscherne DM, Syder AJ, Panis M, Wolk B, Hatziioannou T, McKeating JA, Bieniasz PD, Rice CM (2007) Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446:801\u2013805. doi: 10.1038\/nature05654","journal-title":"Nature"},{"key":"15_CR40","doi-asserted-by":"publisher","first-page":"e1001130","DOI":"10.1371\/journal.ppat.1001130","volume":"6","author":"NS Eyre","year":"2010","unstructured":"Eyre NS, Drummer HE, Beard MR (2010) The SR-BI partner PDZK1 facilitates hepatitis C virus entry. PLoS Pathog 6:e1001130. doi: 10.1371\/journal.ppat.1001130","journal-title":"PLoS Pathog"},{"key":"15_CR41","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0021-9150(98)00084-7","volume":"139","author":"KR Feingold","year":"1998","unstructured":"Feingold KR, Memon RA, Moser AH, Grunfeld C (1998) Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response. Atherosclerosis 139:307\u2013315","journal-title":"Atherosclerosis"},{"key":"15_CR42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.atherosclerosis.2007.10.007","volume":"199","author":"KR Feingold","year":"2008","unstructured":"Feingold KR, Shigenaga JK, Chui LG, Moser A, Khovidhunkit W, Grunfeld C (2008) Infection and inflammation decrease apolipoprotein M expression. Atherosclerosis 199:19\u201326. doi: 10.1016\/j.atherosclerosis.2007.10.007\/S0021-9150(07)00660-0","journal-title":"Atherosclerosis"},{"key":"15_CR43","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.atherosclerosis.2010.01.011","volume":"211","author":"ML Fitzgerald","year":"2010","unstructured":"Fitzgerald ML, Mujawar Z, Tamehiro N (2010) ABC transporters, atherosclerosis and inflammation. Atherosclerosis 211:361\u2013370. doi: 10.1016\/j.atherosclerosis.2010.01.011","journal-title":"Atherosclerosis"},{"key":"15_CR44","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.1128\/IAI.61.12.5140-5146.1993","volume":"61","author":"WA Flegel","year":"1993","unstructured":"Flegel WA, Baumstark MW, Weinstock C, Berg A, Northoff H (1993) Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I. Infect Immun 61:5140\u20135146","journal-title":"Infect Immun"},{"key":"15_CR45","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1161\/ATVBAHA.109.192088","volume":"29","author":"R Franssen","year":"2009","unstructured":"Franssen R, Sankatsing RR, Hassink E, Hutten B, Ackermans MT, Brinkman K, Oesterholt R, Arenas-Pinto A, Storfer SP, Kastelein JJ, Sauerwein HP, Reiss P, Stroes ES (2009) Nevirapine increases high-density lipoprotein cholesterol concentration by stimulation of apolipoprotein A-I production. Arterioscler Thromb Vasc Biol 29:1336\u20131341. doi: 10.1161\/ATVBAHA.109.192088","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"15_CR46","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nature01195","volume":"420","author":"C Garlanda","year":"2002","unstructured":"Garlanda C, Hirsch E, Bozza S, Salustri A, De Acetis M, Nota R, Maccagno A, Riva F, Bottazzi B, Peri G, Doni A, Vago L, Botto M, De Santis R, Carminati P, Siracusa G, Altruda F, Vecchi A, Romani L, Mantovani A (2002) Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 420:182\u2013186","journal-title":"Nature"},{"key":"15_CR47","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1146\/annurev.immunol.23.021704.115756","volume":"23","author":"C Garlanda","year":"2005","unstructured":"Garlanda C, Bottazzi B, Bastone A, Mantovani A (2005) Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 23:337\u2013366","journal-title":"Annu Rev Immunol"},{"key":"15_CR48","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1084\/jem.192.9.1353","volume":"192","author":"D Gershov","year":"2000","unstructured":"Gershov D, Kim S, Brot N, Elkon KB (2000) C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J Exp Med 192:1353\u20131364","journal-title":"J Exp Med"},{"key":"15_CR49","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0022-2275(20)33363-0","volume":"40","author":"C Grunfeld","year":"1999","unstructured":"Grunfeld C, Marshall M, Shigenaga JK, Moser AH, Tobias P, Feingold KR (1999) Lipoproteins inhibit macrophage activation by lipoteichoic acid. J Lipid Res 40:245\u2013252","journal-title":"J Lipid Res"},{"key":"15_CR50","doi-asserted-by":"publisher","first-page":"17947","DOI":"10.1074\/jbc.M112.442699","volume":"288","author":"L Guo","year":"2013","unstructured":"Guo L, Ai J, Zheng Z, Howatt DA, Daugherty A, Huang B, Li XA (2013) High density lipoprotein protects against polymicrobe-induced sepsis in mice. J Biol Chem 288:17947\u201317953. doi: 10.1074\/jbc.M112.442699","journal-title":"J Biol Chem"},{"key":"15_CR51","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1161\/01.RES.0000176530.66400.48","volume":"97","author":"H Gupta","year":"2005","unstructured":"Gupta H, Dai L, Datta G, Garber DW, Grenett H, Li Y, Mishra V, Palgunachari MN, Handattu S, Gianturco SH, Bradley WA, Anantharamaiah GM, White CR (2005) Inhibition of lipopolysaccharide-induced inflammatory responses by an apolipoprotein AI mimetic peptide. Circ Res 97:236\u2013243","journal-title":"Circ Res"},{"issue":"1719\u20131728","key":"15_CR52","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1053\/j.gastro.2008.07.018","volume":"135","author":"A Haberstroh","year":"2008","unstructured":"Haberstroh A, Schnober EK, Zeisel MB, Carolla P, Barth H, Blum HE, Cosset FL, Koutsoudakis G, Bartenschlager R, Union A, Depla E, Owsianka A, Patel AH, Schuster C, Stoll-Keller F, Doffoel M, Dreux M, Baumert TF (2008) Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion. Gastroenterology 135(1719\u20131728):e1. doi: 10.1053\/j.gastro.2008.07.018","journal-title":"Gastroenterology"},{"key":"15_CR53","doi-asserted-by":"publisher","first-page":"5007","DOI":"10.1128\/JVI.02286-07","volume":"82","author":"HJ Harris","year":"2008","unstructured":"Harris HJ, Farquhar MJ, Mee CJ, Davis C, Reynolds GM, Jennings A, Hu K, Yuan F, Deng H, Hubscher SG, Han JH, Balfe P, McKeating JA (2008) CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry. J Virol 82:5007\u20135020. doi: 10.1128\/JVI.02286-07","journal-title":"J Virol"},{"key":"15_CR54","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/1753425910370709","volume":"17","author":"MF Henning","year":"2011","unstructured":"Henning MF, Herlax V, Bakas L (2011) Contribution of the C-terminal end of apolipoprotein AI to neutralization of lipopolysaccharide endotoxic effect. Innate Immun 17:327\u2013337","journal-title":"Innate Immun"},{"key":"15_CR55","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1128\/JVI.67.4.1953-1958.1993","volume":"67","author":"M Hijikata","year":"1993","unstructured":"Hijikata M, Shimizu YK, Kato H, Iwamoto A, Shih JW, Alter HJ, Purcell RH, Yoshikura H (1993) Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J Virol 67:1953\u20131958","journal-title":"J Virol"},{"key":"15_CR56","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1136\/jmg.2006.038356","volume":"43","author":"SE Humphries","year":"2006","unstructured":"Humphries SE, Whittall RA, Hubbart CS, Maplebeck S, Cooper JA, Soutar AK, Naoumova R, Thompson GR, Seed M, Durrington PN, Miller JP, Betteridge DJ, Neil HA (2006) Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk. J Med Genet 43:943\u2013949","journal-title":"J Med Genet"},{"key":"15_CR57","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1126\/science.1183021","volume":"327","author":"A Iwasaki","year":"2010","unstructured":"Iwasaki A, Medzhitov R (2010) Regulation of adaptive immunity by the innate immune system. Science 327:291\u2013295. doi: 10.1126\/science.1183021\/327\/5963\/291","journal-title":"Science"},{"key":"15_CR58","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/cdd.2008.173","volume":"16","author":"S Jaillon","year":"2009","unstructured":"Jaillon S, Jeannin P, Hamon Y, Fremaux I, Doni A, Bottazzi B, Blanchard S, Subra JF, Chevailler A, Mantovani A, Delneste Y (2009) Endogenous PTX3 translocates at the membrane of late apoptotic human neutrophils and is involved in their engulfment by macrophages. Cell Death Differ 16:465\u2013474. doi: 10.1038\/cdd.2008.173","journal-title":"Cell Death Differ"},{"key":"15_CR59","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.immuni.2005.03.008","volume":"22","author":"P Jeannin","year":"2005","unstructured":"Jeannin P, Bottazzi B, Sironi M, Doni A, Rusnati M, Presta M, Maina V, Magistrelli G, Haeuw JF, Hoeffel G, Thieblemont N, Corvaia N, Garlanda C, Delneste Y, Mantovani A (2005) Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors. Immunity 22:551\u2013560. doi: 10.1016\/j.immuni.2005.03.008\/S1074-7613(05)00103-2","journal-title":"Immunity"},{"key":"15_CR60","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ijmm.2007.04.001","volume":"297","author":"R Jerala","year":"2007","unstructured":"Jerala R (2007) Structural biology of the LPS recognition. Int J Med Microbiol 297:353\u2013363. doi: 10.1016\/j.ijmm.2007.04.001\/S1438-4221(07)00068-9","journal-title":"Int J Med Microbiol"},{"key":"15_CR61","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cyto.2008.04.002","volume":"43","author":"YL Jiao","year":"2008","unstructured":"Jiao YL, Wu MP (2008) Apolipoprotein A-I diminishes acute lung injury and sepsis in mice induced by lipoteichoic acid. Cytokine 43:83\u201387. doi: 10.1016\/j.cyto.2008.04.002\/S1043-4666(08)00099-9","journal-title":"Cytokine"},{"key":"15_CR62","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1476-511X-10-35","volume":"10","author":"T Kelesidis","year":"2011","unstructured":"Kelesidis T, Yang OO, Currier JS, Navab K, Fogelman AM, Navab M (2011) HIV-1 infected patients with suppressed plasma viremia on treatment have pro-inflammatory HDL. Lipids Health Dis 10:35. doi: 10.1186\/1476-511X-10-35","journal-title":"Lipids Health Dis"},{"key":"15_CR63","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1476-511X-12-23","volume":"12","author":"T Kelesidis","year":"2013","unstructured":"Kelesidis T, Yang OO, Kendall MA, Hodis HN, Currier JS (2013) Dysfunctional HDL and progression of atherosclerosis in HIV-1-infected and -uninfected adults. Lipids Health Dis 12:23. doi: 10.1186\/1476-511X-12-23","journal-title":"Lipids Health Dis"},{"key":"15_CR64","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","volume":"45","author":"W Khovidhunkit","year":"2004","unstructured":"Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR, Grunfeld C (2004) Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 45:1169\u20131196","journal-title":"J Lipid Res"},{"key":"15_CR65","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1124\/pr.58.3.1","volume":"58","author":"A Kontush","year":"2006","unstructured":"Kontush A, Chapman MJ (2006) Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol Rev 58:342\u2013374","journal-title":"Pharmacol Rev"},{"key":"15_CR66","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/hep.23445","volume":"51","author":"SE Krieger","year":"2010","unstructured":"Krieger SE, Zeisel MB, Davis C, Thumann C, Harris HJ, Schnober EK, Mee C, Soulier E, Royer C, Lambotin M, Grunert F, Dao Thi VL, Dreux M, Cosset FL, McKeating JA, Schuster C, Baumert TF (2010) Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations. Hepatology 51:1144\u20131157. doi: 10.1002\/hep.23445","journal-title":"Hepatology"},{"key":"15_CR67","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/cc11305","volume":"16","author":"SB Kumaraswamy","year":"2012","unstructured":"Kumaraswamy SB, Linder A, Akesson P, Dahlback B (2012) Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes. Crit Care 16:R60. doi: 10.1186\/cc11305\/cc11305","journal-title":"Crit Care"},{"key":"15_CR68","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1097\/TA.0b013e3182493ab4","volume":"72","author":"WY Kwon","year":"2012","unstructured":"Kwon WY, Suh GJ, Kim KS, Kwak YH, Kim K (2012) 4F, apolipoprotein AI mimetic peptide, attenuates acute lung injury and improves survival in endotoxemic rats. J Trauma Acute Care Surg 72:1576\u20131583. doi: 10.1097\/TA.0b013e3182493ab4\/01586154-201206000-00023","journal-title":"J Trauma Acute Care Surg"},{"key":"15_CR69","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/hep.21406","volume":"44","author":"M Lavie","year":"2006","unstructured":"Lavie M, Voisset C, Vu-Dac N, Zurawski V, Duverlie G, Wychowski C, Dubuisson J (2006) Serum amyloid A has antiviral activity against hepatitis C virus by inhibiting virus entry in a cell culture system. Hepatology 44:1626\u20131634. doi: 10.1002\/hep.21406","journal-title":"Hepatology"},{"key":"15_CR70","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.4049\/jimmunol.150.5.1804","volume":"150","author":"GW Lee","year":"1993","unstructured":"Lee GW, Lee TH, Vilcek J (1993) TSG-14, a tumor necrosis factor- and IL-1-inducible protein, is a novel member of the pentaxin family of acute phase proteins. J Immunol 150:1804\u20131812","journal-title":"J Immunol"},{"key":"15_CR71","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/nur.20187","volume":"30","author":"RP Lee","year":"2007","unstructured":"Lee RP, Lin NT, Chao YF, Lin CC, Harn HJ, Chen HI (2007) High-density lipoprotein prevents organ damage in endotoxemia. Res Nurs Health 30:250\u2013260. doi: 10.1002\/nur.20187","journal-title":"Res Nurs Health"},{"key":"15_CR72","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1128\/IAI.71.6.3280-3284.2003","volume":"71","author":"JH Levels","year":"2003","unstructured":"Levels JH, Abraham PR, van Barreveld EP, Meijers JC, van Deventer SJ (2003) Distribution and kinetics of lipoprotein-bound lipoteichoic acid. Infect Immun 71:3280\u20133284","journal-title":"Infect Immun"},{"key":"15_CR73","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1477-5956-9-34","volume":"9","author":"JH Levels","year":"2011","unstructured":"Levels JH, Geurts P, Karlsson H, Maree R, Ljunggren S, Fornander L, Wehenkel L, Lindahl M, Stroes ES, Kuivenhoven JA, Meijers JC (2011) High-density lipoprotein proteome dynamics in human endotoxemia. Proteome Sci 9:34. doi: 10.1186\/1477-5956-9-34","journal-title":"Proteome Sci"},{"key":"15_CR74","doi-asserted-by":"publisher","first-page":"12040","DOI":"10.1073\/pnas.90.24.12040","volume":"90","author":"DM Levine","year":"1993","unstructured":"Levine DM, Parker TS, Donnelly TM, Walsh A, Rubin AL (1993) In vivo protection against endotoxin by plasma high density lipoprotein. Proc Natl Acad Sci USA 90:12040\u201312044","journal-title":"Proc Natl Acad Sci USA"},{"key":"15_CR75","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ejphar.2008.06.047","volume":"590","author":"Y Li","year":"2008","unstructured":"Li Y, Dong JB, Wu MP (2008) Human ApoA-I overexpression diminishes LPS-induced systemic inflammation and multiple organ damage in mice. Eur J Pharmacol 590:417\u2013422. doi: 10.1016\/j.ejphar.2008.06.047\/S0014-2999(08)00656-0","journal-title":"Eur J Pharmacol"},{"key":"15_CR76","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nm.2341","volume":"17","author":"J Lupberger","year":"2011","unstructured":"Lupberger J, Zeisel MB, Xiao F, Thumann C, Fofana I, Zona L, Davis C, Mee CJ, Turek M, Gorke S, Royer C, Fischer B, Zahid MN, Lavillette D, Fresquet J, Cosset FL, Rothenberg SM, Pietschmann T, Patel AH, Pessaux P, Doffoel M, Raffelsberger W, Poch O, McKeating JA, Brino L, Baumert TF (2011) EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat Med 17:589\u2013595. doi: 10.1038\/nm.2341","journal-title":"Nat Med"},{"key":"15_CR77","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1161\/01.ATV.0000042080.46554.E6","volume":"22","author":"NR Madamanchi","year":"2002","unstructured":"Madamanchi NR, Patterson C, Runge MS (2002) HIV therapies and atherosclerosis: answers or questions? Arterioscler Thromb Vasc Biol 22:1758\u20131760","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"15_CR78","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1096\/fj.05-4728fje","volume":"20","author":"P Maillard","year":"2006","unstructured":"Maillard P, Huby T, Andreo U, Moreau M, Chapman J, Budkowska A (2006) The interaction of natural hepatitis C virus with human scavenger receptor SR-BI\/Cla1 is mediated by ApoB-containing lipoproteins. FASEB J 20:735\u2013737. doi: 10.1096\/fj.05-4728fje","journal-title":"FASEB J"},{"key":"15_CR79","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1136\/gut.2010.211292","volume":"60","author":"C Mancone","year":"2011","unstructured":"Mancone C, Steindler C, Santangelo L, Simonte G, Vlassi C, Longo MA, D'Offizi G, Di Giacomo C, Pucillo LP, Amicone L, Tripodi M, Alonzi T (2011) Hepatitis C virus production requires apolipoprotein A-I and affects its association with nascent low-density lipoproteins. Gut 60:378\u2013386. doi: 10.1136\/gut.2010.211292","journal-title":"Gut"},{"key":"15_CR80","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/CIRCULATIONAHA.108.810721","volume":"119","author":"FC McGillicuddy","year":"2009","unstructured":"McGillicuddy FC, de la Llera MM, Hinkle CC, Joshi MR, Chiquoine EH, Billheimer JT, Rothblat GH, Reilly MP (2009) Inflammation impairs reverse cholesterol transport in vivo. Circulation 119:1135\u20131145","journal-title":"Circulation"},{"key":"15_CR81","first-page":"R94","volume":"277","author":"RA Memon","year":"1999","unstructured":"Memon RA, Fuller J, Moser AH, Feingold KR, Grunfeld C (1999) In vivo regulation of plasma platelet-activating factor acetylhydrolase during the acute phase response. Am J Physiol 277:R94\u2013R103","journal-title":"Am J Physiol"},{"key":"15_CR82","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/hep.24692","volume":"55","author":"P Meuleman","year":"2012","unstructured":"Meuleman P, Catanese MT, Verhoye L, Desombere I, Farhoudi A, Jones CT, Sheahan T, Grzyb K, Cortese R, Rice CM, Leroux-Roels G, Nicosia A (2012) A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo. Hepatology 55:364\u2013372. doi: 10.1002\/hep.24692","journal-title":"Hepatology"},{"key":"15_CR83","doi-asserted-by":"publisher","first-page":"e365","DOI":"10.1371\/journal.pbio.0040365","volume":"4","author":"Z Mujawar","year":"2006","unstructured":"Mujawar Z, Rose H, Morrow MP, Pushkarsky T, Dubrovsky L, Mukhamedova N, Fu Y, Dart A, Orenstein JM, Bobryshev YV, Bukrinsky M, Sviridov D (2006) Human immunodeficiency virus impairs reverse cholesterol transport from macrophages. PLoS Biol 4:e365. doi: 10.1371\/journal.pbio.0040365","journal-title":"PLoS Biol"},{"key":"15_CR84","doi-asserted-by":"publisher","first-page":"8338","DOI":"10.1021\/bi100466q","volume":"49","author":"Z Mujawar","year":"2010","unstructured":"Mujawar Z, Tamehiro N, Grant A, Sviridov D, Bukrinsky M, Fitzgerald ML (2010) Mutation of the ATP cassette binding transporter A1 (ABCA1) C-terminus disrupts HIV-1 Nef binding but does not block the Nef enhancement of ABCA1 protein degradation. Biochemistry 49:8338\u20138349. doi: 10.1021\/bi100466q","journal-title":"Biochemistry"},{"key":"15_CR85","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00134-006-0432-y","volume":"33","author":"O Murch","year":"2007","unstructured":"Murch O, Collin M, Hinds CJ, Thiemermann C (2007) Lipoproteins in inflammation and sepsis. I. Basic science. Intensive Care Med 33:13\u201324","journal-title":"Intensive Care Med"},{"key":"15_CR86","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1161\/ATVBAHA.111.226258","volume":"31","author":"AJ Murphy","year":"2011","unstructured":"Murphy AJ, Woollard KJ, Suhartoyo A, Stirzaker RA, Shaw J, Sviridov D, Chin-Dusting JP (2011) Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein a-I in in vitro and in vivo models of inflammation. Arterioscler Thromb Vasc Biol 31:1333\u20131341","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"15_CR87","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/immu.200310022","volume":"33","author":"AJ Nauta","year":"2003","unstructured":"Nauta AJ, Bottazzi B, Mantovani A, Salvatori G, Kishore U, Schwaeble WJ, Gingras AR, Tzima S, Vivanco F, Egido J, Tijsma O, Hack EC, Daha MR, Roos A (2003) Biochemical and functional characterization of the interaction between pentraxin 3 and C1q. Eur J Immunol 33:465\u2013473. doi: 10.1002\/immu.200310022","journal-title":"Eur J Immunol"},{"key":"15_CR88","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1194\/jlr.R400001-JLR200","volume":"45","author":"M Navab","year":"2004","unstructured":"Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fonarow GC, Vahabzadeh K, Hama S, Hough G, Kamranpour N, Berliner JA, Lusis AJ, Fogelman AM (2004) The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res 45:993\u20131007","journal-title":"J Lipid Res"},{"key":"15_CR89","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1128\/JVI.80.5.2418-2428.2006","volume":"80","author":"SU Nielsen","year":"2006","unstructured":"Nielsen SU, Bassendine MF, Burt AD, Martin C, Pumeechockchai W, Toms GL (2006) Association between hepatitis C virus and very-low-density lipoprotein (VLDL)\/LDL analyzed in iodixanol density gradients. J Virol 80:2418\u20132428. doi: 10.1128\/JVI.80.5.2418-2428.2006","journal-title":"J Virol"},{"key":"15_CR90","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1161\/CIRCULATIONAHA.104.472886","volume":"111","author":"GD Norata","year":"2005","unstructured":"Norata GD, Callegari E, Marchesi M, Chiesa G, Eriksson P, Catapano AL (2005) High-density lipoproteins induce transforming growth factor-beta2 expression in endothelial cells. Circulation 111:2805\u20132811","journal-title":"Circulation"},{"issue":"5","key":"15_CR91","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.numecd.2006.01.012","volume":"16","author":"GD Norata","year":"2006","unstructured":"Norata GD, Pirillo A, Catapano AL (2006) Modified HDL: biological and physiopathological consequences. Nutr Metab Cardiovasc Dis 16(5):371\u2013386","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"15_CR92","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1161\/ATVBAHA.107.160606","volume":"28","author":"GD Norata","year":"2008","unstructured":"Norata GD, Marchesi P, Pirillo A, Uboldi P, Chiesa G, Maina V, Garlanda C, Mantovani A, Catapano AL (2008) Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells. Arterioscler Thromb Vasc Biol 28:925\u2013931. doi: 10.1161\/ATVBAHA.107.160606","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"15_CR93","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1161\/CIRCULATIONAHA.108.806547","volume":"120","author":"GD Norata","year":"2009","unstructured":"Norata GD, Marchesi P, Pulakazhi Venu VK, Pasqualini F, Anselmo A, Moalli F, Pizzitola I, Garlanda C, Mantovani A, Catapano AL (2009) Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis. Circulation 120:699\u2013708. doi: 10.1161\/CIRCULATIONAHA.108.806547","journal-title":"Circulation"},{"key":"15_CR94","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.tcm.2010.03.005","volume":"20","author":"GD Norata","year":"2010","unstructured":"Norata GD, Garlanda C, Catapano AL (2010) The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases. Trends Cardiovasc Med 20:35\u201340. doi: 10.1016\/j.tcm.2010.03.005\/S1050-1738(10)00036-8","journal-title":"Trends Cardiovasc Med"},{"key":"15_CR95","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/MOL.0b013e32834adac3","volume":"22","author":"GD Norata","year":"2011","unstructured":"Norata GD, Pirillo A, Catapano AL (2011) HDLs, immunity, and atherosclerosis. Curr Opin Lipidol 22:410\u2013416. doi: 10.1097\/MOL.0b013e32834adac3","journal-title":"Curr Opin Lipidol"},{"key":"15_CR96","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2011.06.045","volume":"220","author":"GD Norata","year":"2012","unstructured":"Norata GD, Pirillo A, Ammirati E, Catapano AL (2012) Emerging role of high density lipoproteins as a player in the immune system. Atherosclerosis 220:11\u201321. doi: 10.1016\/j.atherosclerosis.2011.06.045","journal-title":"Atherosclerosis"},{"key":"15_CR97","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1084\/jem.184.5.1601","volume":"184","author":"D Pajkrt","year":"1996","unstructured":"Pajkrt D, Doran JE, Koster F, Lerch PG, Arnet B, van der Poll T, ten Cate JW, van Deventer SJ (1996) Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia. J Exp Med 184:1601\u20131608","journal-title":"J Exp Med"},{"key":"15_CR98","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1128\/IAI.63.1.253-258.1995","volume":"63","author":"TS Parker","year":"1995","unstructured":"Parker TS, Levine DM, Chang JC, Laxer J, Coffin CC, Rubin AL (1995) Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood. Infect Immun 63:253\u2013258","journal-title":"Infect Immun"},{"issue":"23","key":"15_CR99","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1056\/NEJMoa1310345","volume":"369","author":"A Parsa","year":"2013","unstructured":"Parsa A, Kao WH, Xie D, Astor BC, Li M, Hsu CY, Feldman HI, Parekh RS, Kusek JW, Greene TH, Fink JC, Anderson AH, Choi MJ, Wright JT Jr, Lash JP, Freedman BI, Ojo A, Winkler CA, Raj DS, Kopp JB, He J, Jensvold NG, Tao K, Lipkowitz MS, Appel LJ, AASK Study Investigators, CRIC Study Investigators (2013) APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med 369(23):2183\u20132196. doi: 10.1056\/NEJMoa1310345","journal-title":"N Engl J Med"},{"key":"15_CR100","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/j.1365-2125.2009.03535.x","volume":"68","author":"SA Pereira","year":"2009","unstructured":"Pereira SA, Batuca JR, Caixas U, Branco T, Delgado-Alves J, Germano I, Lampreia F, Monteiro EC (2009) Effect of efavirenz on high-density lipoprotein antioxidant properties in HIV-infected patients. Br J Clin Pharmacol 68:891\u2013897. doi: 10.1111\/j.1365-2125.2009.03535.x","journal-title":"Br J Clin Pharmacol"},{"key":"15_CR101","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1126\/science.1114566","volume":"309","author":"D Perez-Morga","year":"2005","unstructured":"Perez-Morga D, Vanhollebeke B, Paturiaux-Hanocq F, Nolan DP, Lins L, Homble F, Vanhamme L, Tebabi P, Pays A, Poelvoorde P, Jacquet A, Brasseur R, Pays E (2005) Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes. Science 309:469\u2013472. doi: 10.1126\/science.1114566","journal-title":"Science"},{"key":"15_CR102","doi-asserted-by":"publisher","first-page":"3841","DOI":"10.2174\/13816128113199990298","volume":"19","author":"A Pirillo","year":"2013","unstructured":"Pirillo A, Norata GD, Catapano AL (2013) Treating high density lipoprotein cholesterol (HDL-C): quantity versus quality. Curr Pharm Des 19:3841\u20133857","journal-title":"Curr Pharm Des"},{"key":"15_CR103","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/nature07684","volume":"457","author":"A Ploss","year":"2009","unstructured":"Ploss A, Evans MJ, Gaysinskaya VA, Panis M, You H, de Jong YP, Rice CM (2009) Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457:882\u2013886. doi: 10.1038\/nature07684","journal-title":"Nature"},{"key":"15_CR104","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/cdd.2009.195","volume":"17","author":"IK Poon","year":"2010","unstructured":"Poon IK, Hulett MD, Parish CR (2010) Molecular mechanisms of late apoptotic\/necrotic cell clearance. Cell Death Differ 17:381\u2013397. doi: 10.1038\/cdd.2009.195","journal-title":"Cell Death Differ"},{"key":"15_CR105","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.4049\/jimmunol.180.5.3391","volume":"180","author":"PC Reading","year":"2008","unstructured":"Reading PC, Bozza S, Gilbertson B, Tate M, Moretti S, Job ER, Crouch EC, Brooks AG, Brown LE, Bottazzi B, Romani L, Mantovani A (2008) Antiviral activity of the long chain pentraxin PTX3 against influenza viruses. J Immunol 180:3391\u20133398","journal-title":"J Immunol"},{"key":"15_CR106","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1001\/jama.289.22.2978","volume":"289","author":"SA Riddler","year":"2003","unstructured":"Riddler SA, Smit E, Cole SR, Li R, Chmiel JS, Dobs A, Palella F, Visscher B, Evans R, Kingsley LA (2003) Impact of HIV infection and HAART on serum lipids in men. JAMA 289:2978\u20132982. doi: 10.1001\/jama.289.22.2978","journal-title":"JAMA"},{"key":"15_CR107","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.metabol.2005.07.012","volume":"55","author":"H Rose","year":"2006","unstructured":"Rose H, Woolley I, Hoy J, Dart A, Bryant B, Mijch A, Sviridov D (2006) HIV infection and high-density lipoprotein: the effect of the disease vs the effect of treatment. Metabolism 55:90\u201395. doi: 10.1016\/j.metabol.2005.07.012","journal-title":"Metabolism"},{"key":"15_CR108","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.atherosclerosis.2007.10.018","volume":"199","author":"H Rose","year":"2008","unstructured":"Rose H, Hoy J, Woolley I, Tchoua U, Bukrinsky M, Dart A, Sviridov D (2008) HIV infection and high density lipoprotein metabolism. Atherosclerosis 199:79\u201386. doi: 10.1016\/j.atherosclerosis.2007.10.018","journal-title":"Atherosclerosis"},{"key":"15_CR109","doi-asserted-by":"publisher","first-page":"4093","DOI":"10.1021\/bi052646f","volume":"45","author":"LT Roumenina","year":"2006","unstructured":"Roumenina LT, Ruseva MM, Zlatarova A, Ghai R, Kolev M, Olova N, Gadjeva M, Agrawal A, Bottazzi B, Mantovani A, Reid KB, Kishore U, Kojouharova MS (2006) Interaction of C1q with IgG1, C-reactive protein and pentraxin 3: mutational studies using recombinant globular head modules of human C1q A, B, and C chains. Biochemistry 45:4093\u20134104. doi: 10.1021\/bi052646f","journal-title":"Biochemistry"},{"key":"15_CR110","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1182\/blood.V96.13.4300","volume":"96","author":"P Rovere","year":"2000","unstructured":"Rovere P, Peri G, Fazzini F, Bottazzi B, Doni A, Bondanza A, Zimmermann VS, Garlanda C, Fascio U, Sabbadini MG, Rugarli C, Mantovani A, Manfredi AA (2000) The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells. Blood 96:4300\u20134306","journal-title":"Blood"},{"key":"15_CR111","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3724\/SP.J.1263.2011.12282","volume":"9","author":"F Sala","year":"2012","unstructured":"Sala F, Catapano AL, Norata GD (2012) High density lipoproteins and atherosclerosis: emerging aspects. J Geriatr Cardiol 9:401\u2013407. doi: 10.3724\/SP.J.1263.2011.12282","journal-title":"J Geriatr Cardiol"},{"key":"15_CR112","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1016\/j.ijcard.2013.03.103","volume":"168","author":"F Sala","year":"2013","unstructured":"Sala F, Cutuli L, Grigore L, Pirillo A, Chiesa G, Catapano AL, Norata GD (2013) Prevalence of classical CD14++\/CD16\u2212 but not of intermediate CD14++\/CD16+ monocytes in hypoalphalipoproteinemia. Int J Cardiol 168:2886\u20132889. doi: 10.1016\/j.ijcard.2013.03.103","journal-title":"Int J Cardiol"},{"key":"15_CR113","doi-asserted-by":"publisher","first-page":"e1000276","DOI":"10.1371\/journal.ppat.1000276","volume":"5","author":"M Samanovic","year":"2009","unstructured":"Samanovic M, Molina-Portela MP, Chessler AD, Burleigh BA, Raper J (2009) Trypanosome lytic factor, an antimicrobial high-density lipoprotein, ameliorates Leishmania infection. PLoS Pathog 5:e1000276. doi: 10.1371\/journal.ppat.1000276","journal-title":"PLoS Pathog"},{"key":"15_CR114","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.1093\/emboj\/cdf529","volume":"21","author":"E Scarselli","year":"2002","unstructured":"Scarselli E, Ansuini H, Cerino R, Roccasecca RM, Acali S, Filocamo G, Traboni C, Nicosia A, Cortese R, Vitelli A (2002) The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 21:5017\u20135025","journal-title":"EMBO J"},{"key":"15_CR115","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/CRD.0b013e3181c4b508","volume":"18","author":"CB Sherman","year":"2010","unstructured":"Sherman CB, Peterson SJ, Frishman WH (2010) Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosis. Cardiol Rev 18:141\u2013147. doi: 10.1097\/CRD.0b013e3181c4b508","journal-title":"Cardiol Rev"},{"key":"15_CR116","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/0002-9343(93)90087-6","volume":"94","author":"G Shor-Posner","year":"1993","unstructured":"Shor-Posner G, Basit A, Lu Y, Cabrejos C, Chang J, Fletcher M, Mantero-Atienza E, Baum MK (1993) Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection. Am J Med 94:515\u2013519","journal-title":"Am J Med"},{"key":"15_CR117","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/0042-6822(90)90229-K","volume":"176","author":"RV Srinivas","year":"1990","unstructured":"Srinivas RV, Birkedal B, Owens RJ, Anantharamaiah GM, Segrest JP, Compans RW (1990) Antiviral effects of apolipoprotein A-I and its synthetic amphipathic peptide analogs. Virology 176:48\u201357","journal-title":"Virology"},{"key":"15_CR118","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1161\/CIRCULATIONAHA.110.961193","volume":"122","author":"M Suzuki","year":"2010","unstructured":"Suzuki M, Pritchard DK, Becker L, Hoofnagle AN, Tanimura N, Bammler TK, Beyer RP, Bumgarner R, Vaisar T, de Beer MC, de Beer FC, Miyake K, Oram JF, Heinecke JW (2010) High-density lipoprotein suppresses the type I interferon response, a family of potent antiviral immunoregulators, in macrophages challenged with lipopolysaccharide. Circulation 122:1919\u20131927","journal-title":"Circulation"},{"key":"15_CR119","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jhep.2010.06.024","volume":"54","author":"AJ Syder","year":"2011","unstructured":"Syder AJ, Lee H, Zeisel MB, Grove J, Soulier E, Macdonald J, Chow S, Chang J, Baumert TF, McKeating JA, McKelvy J, Wong-Staal F (2011) Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors. J Hepatol 54:48\u201355. doi: 10.1016\/j.jhep.2010.06.024","journal-title":"J Hepatol"},{"key":"15_CR120","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.4049\/jimmunol.177.7.4880","volume":"177","author":"PA Thompson","year":"2006","unstructured":"Thompson PA, Kitchens RL (2006) Native high-density lipoprotein augments monocyte responses to lipopolysaccharide (LPS) by suppressing the inhibitory activity of LPS-binding protein. J Immunol 177:4880\u20134887. doi: 10.4049\/jimmunol.177.7.4880","journal-title":"J Immunol"},{"key":"15_CR121","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/BF00198849","volume":"181","author":"R Thomssen","year":"1992","unstructured":"Thomssen R, Bonk S, Propfe C, Heermann KH, Kochel HG, Uy A (1992) Association of hepatitis C virus in human sera with beta-lipoprotein. Med Microbiol Immunol 181:293\u2013300","journal-title":"Med Microbiol Immunol"},{"key":"15_CR122","doi-asserted-by":"crossref","first-page":"10867","DOI":"10.1016\/S0021-9258(18)81700-8","volume":"264","author":"PS Tobias","year":"1989","unstructured":"Tobias PS, Soldau K, Ulevitch RJ (1989) Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein. J Biol Chem 264:10867\u201310871","journal-title":"J Biol Chem"},{"key":"15_CR123","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1172\/JCI109610","volume":"64","author":"RJ Ulevitch","year":"1979","unstructured":"Ulevitch RJ, Johnston AR, Weinstein DB (1979) New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides. J Clin Invest 64:1516\u20131524. doi: 10.1172\/JCI109610","journal-title":"J Clin Invest"},{"key":"15_CR124","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1172\/JCI110100","volume":"67","author":"RJ Ulevitch","year":"1981","unstructured":"Ulevitch RJ, Johnston AR, Weinstein DB (1981) New function for high density lipoproteins. Isolation and characterization of a bacterial lipopolysaccharide-high density lipoprotein complex formed in rabbit plasma. J Clin Invest 67:827\u2013837. doi: 10.1172\/JCI110100","journal-title":"J Clin Invest"},{"key":"15_CR125","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1128\/CMR.16.3.379-414.2003","volume":"16","author":"ES Amersfoort Van","year":"2003","unstructured":"Van Amersfoort ES, Van Berkel TJ, Kuiper J (2003) Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin Microbiol Rev 16:379\u2013414","journal-title":"Clin Microbiol Rev"},{"key":"15_CR126","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1097\/01.CCM.0000059724.08290.51","volume":"31","author":"HJ Leeuwen van","year":"2003","unstructured":"van Leeuwen HJ, Heezius EC, Dallinga GM, van Strijp JA, Verhoef J, van Kessel KP (2003) Lipoprotein metabolism in patients with severe sepsis. Crit Care Med 31:1359\u20131366","journal-title":"Crit Care Med"},{"key":"15_CR127","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1002\/art.20370","volume":"50","author":"AP Rossum van","year":"2004","unstructured":"van Rossum AP, Fazzini F, Limburg PC, Manfredi AA, Rovere-Querini P, Mantovani A, Kallenberg CG (2004) The prototypic tissue pentraxin PTX3, in contrast to the short pentraxin serum amyloid P, inhibits phagocytosis of late apoptotic neutrophils by macrophages. Arthritis Rheum 50:2667\u20132674. doi: 10.1002\/art.20370","journal-title":"Arthritis Rheum"},{"key":"15_CR128","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nature01461","volume":"422","author":"L Vanhamme","year":"2003","unstructured":"Vanhamme L, Paturiaux-Hanocq F, Poelvoorde P, Nolan DP, Lins L, Van Den Abbeele J, Pays A, Tebabi P, Van Xong H, Jacquet A, Moguilevsky N, Dieu M, Kane JP, De Baetselier P, Brasseur R, Pays E (2003) Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature 422:83\u201387. doi: 10.1038\/nature01461","journal-title":"Nature"},{"key":"15_CR129","doi-asserted-by":"publisher","first-page":"22771","DOI":"10.1074\/jbc.M211032200","volume":"278","author":"TG Vishnyakova","year":"2003","unstructured":"Vishnyakova TG, Bocharov AV, Baranova IN, Chen Z, Remaley AT, Csako G, Eggerman TL, Patterson AP (2003) Binding and internalization of lipopolysaccharide by Cla-1, a human orthologue of rodent scavenger receptor B1. J Biol Chem 278:22771\u201322780. doi: 10.1074\/jbc.M211032200","journal-title":"J Biol Chem"},{"key":"15_CR130","doi-asserted-by":"publisher","first-page":"7793","DOI":"10.1074\/jbc.M411600200","volume":"280","author":"C Voisset","year":"2005","unstructured":"Voisset C, Callens N, Blanchard E, Op De Beeck A, Dubuisson J, Vu-Dac N (2005) High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. J Biol Chem 280:7793\u20137799. doi: 10.1074\/jbc.M411600200","journal-title":"J Biol Chem"},{"key":"15_CR131","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/hep.21139","volume":"43","author":"T Hahn von","year":"2006","unstructured":"von Hahn T, Lindenbach BD, Boullier A, Quehenberger O, Paulson M, Rice CM, McKeating JA (2006) Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells. Hepatology 43:932\u2013942. doi: 10.1002\/hep.21139","journal-title":"Hepatology"},{"key":"15_CR132","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00134-006-0433-x","volume":"33","author":"M Wendel","year":"2007","unstructured":"Wendel M, Paul R, Heller AR (2007) Lipoproteins in inflammation and sepsis. II. Clinical aspects. Intensive Care Med 33:25\u201335. doi: 10.1007\/s00134-006-0433-x","journal-title":"Intensive Care Med"},{"key":"15_CR133","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.pt.2010.05.005","volume":"26","author":"RJ Wheeler","year":"2010","unstructured":"Wheeler RJ (2010) The trypanolytic factor-mechanism, impacts and applications. Trends Parasitol 26:457\u2013464. doi: 10.1016\/j.pt.2010.05.005","journal-title":"Trends Parasitol"},{"key":"15_CR134","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2174\/1567270001006010122","volume":"6","author":"CR White","year":"2009","unstructured":"White CR, Datta G, Mochon P, Zhang Z, Kelly O, Curcio C, Parks D, Palgunachari M, Handattu S, Gupta H, Garber DW, Anantharamaiah GM (2009) Vasculoprotective effects of apolipoprotein mimetic peptides: an evolving paradigm in HDL therapy. Vasc Dis Prev 6:122\u2013130. doi: 10.2174\/1567270000906010122","journal-title":"Vasc Dis Prev"},{"key":"15_CR135","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nm1211","volume":"11","author":"C Wolfrum","year":"2005","unstructured":"Wolfrum C, Poy MN, Stoffel M (2005) Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat Med 11:418\u2013422. doi: 10.1038\/nm1211","journal-title":"Nat Med"},{"key":"15_CR136","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/hep.26097","volume":"57","author":"MN Zahid","year":"2013","unstructured":"Zahid MN, Turek M, Xiao F, Thi VL, Guerin M, Fofana I, Bachellier P, Thompson J, Delang L, Neyts J, Bankwitz D, Pietschmann T, Dreux M, Cosset FL, Grunert F, Baumert TF, Zeisel MB (2013) The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination. Hepatology 57:492\u2013504. doi: 10.1002\/hep.26097","journal-title":"Hepatology"},{"key":"15_CR137","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1002\/hep.21994","volume":"46","author":"MB Zeisel","year":"2007","unstructured":"Zeisel MB, Koutsoudakis G, Schnober EK, Haberstroh A, Blum HE, Cosset FL, Wakita T, Jaeck D, Doffoel M, Royer C, Soulier E, Schvoerer E, Schuster C, Stoll-Keller F, Bartenschlager R, Pietschmann T, Barth H, Baumert TF (2007) Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81. Hepatology 46:1722\u20131731. doi: 10.1002\/hep.21994","journal-title":"Hepatology"},{"key":"15_CR138","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.jhep.2010.10.014","volume":"54","author":"MB Zeisel","year":"2011","unstructured":"Zeisel MB, Fofana I, Fafi-Kremer S, Baumert TF (2011) Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies. J Hepatol 54:566\u2013576. doi: 10.1016\/j.jhep.2010.10.014","journal-title":"J Hepatol"}],"container-title":["Handbook of Experimental Pharmacology","High Density Lipoproteins"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-09665-0_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T15:50:34Z","timestamp":1690732234000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-09665-0_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,1]]},"ISBN":["9783319096643","9783319096650"],"references-count":138,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-09665-0_15","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-3-319-09665-0","asserted-by":"object"}]},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,1]]}}}